Fennec Pharmaceuticals Financial Overview
Fennec Pharmaceuticals's market cap is currently C$361.88M. The company's EPS TTM is C$-0.028; its P/E ratio is -31.90; Fennec Pharmaceuticals is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is C$0.05. See an overview of income statement, balance sheet, and cash flow financials.
